Harrington Heart & Vascular Institute

Monday, March 05, 2018

University Hospitals Recruits Top Neuroscientist to Join Harrington Discovery Institute

CLEVELAND – University Hospitals has recruited Andrew Pieper, MD, PhD, one of the nation’s leading physician-scientists in the field of neuropsychiatric disorders. Dr. Pieper joins the Harrington Discovery Institute – part of The Harrington Project for Discovery & Development – at UH. Dr. Pieper also will be a faculty member of the Departments of Psychiatry at UH and the Louis Stokes Cleveland VA Medical Center as well as at Case Western Reserve University School of Medicine. 
 
At the Harrington Discovery Institute, Dr. Pieper will serve as Director of the Alzheimer Drug Discovery Foundation-Harrington Scholar Program, which seeks to advance treatments for Alzheimer’s In addition, Dr. Pieper will serve as co-Director of the Gund-Harrington Scholar program which is focused on accelerating the development of vision-restoring drug therapies. In this leadership capacity, Dr. Pieper will oversee the selection and progress of the ADDF-Harrington and Gund-Harrington grant awardees annually.


Friday, February 02, 2018

University Hospitals launches new vision statement: ‘Advancing the Science of Health and the Art of Compassion’

CLEVELAND – University Hospitals is launching a new vision statement to guide the future success and aspirations of the health system, its 18 hospitals, 26,000 employees and 1.3 million patients annually served.
 
The statement -- Advancing the Science of Health and the Art of Compassion -- defines UH as a nationally leading academic medical research center and health system grounded in pioneering research, new technologies and compassionate and personalized patient care.
 
As part of the vision launch, UH also will kick off an advertising campaign with two commercials airing during the Super Bowl on Feb. 4.  The commercials are part of a series of spots featuring real patients and their caregivers sharing their UH experiences. 
 
Following their initial showings, the commercials will be shown on TV stations in Northeast Ohio, in conjunction with ads on radio, in newspapers and digital platforms.


Thursday, July 13, 2017

University Hospitals appoints Mehdi H. Shishehbor, DO, PhD, MPH as new Director, Cardiovascular Interventional Center

CLEVELAND – University Hospitals Cleveland Medical Center and UH Harrington Heart & Vascular Institute announce the appointment of Mehdi H. Shishehbor, DO, PhD, MPH as Director of Cardiovascular Interventional Center effective Aug. 1, 2017.
 
He also will serve as a Co-Chair, Clinical Executive Committee with UH Cleveland Medical Center and work as the Co-Director, Vascular Center at UH Cleveland Medical Center and UH Harrington Heart & Vascular Institute. 
 
Dr. Shishehbor will receive patients in his new offices beginning Aug. 1.  More information can be found: http://www.uhhospitals.org/services/heart-and-vascular/institute/leadership/mehdi-h-shishehbor.


Wednesday, June 07, 2017

Harrington Discovery Institute announces Gund-Harrington Scholars

CLEVELAND – Harrington Discovery Institute at University Hospitals in Cleveland, Ohio part of The Harrington Project for Discovery & Development, and the Foundation Fighting Blindness have announced their 2017 Gund-Harrington Scholars.
 
Harrington Discovery Institute partnerships are based on a shared mission to advance discoveries of new medicines that will improve human health, as well as, enhance each organization's ability to play a significant role in setting the scientific and innovation agenda in leading-edge research. These awards offer selected winners funding and drug development expertise to ensure the most promising treatments enter clinical trials where their safety and efficacy can be established.
 


Friday, June 02, 2017

Small molecule prevents blood clots without increasing bleeding risk

CLEVELAND – It may be possible to disrupt harmful blood clots in people at risk for heart attack or stroke without increasing their risk of bleeding, according to a new study published in Nature Communications.

The new research out of University Hospitals (UH) Cleveland Medical Center, Case Western Reserve University School of Medicine, and the Cleveland Clinic reveals a previously unknown cell receptor interaction that, when manipulated with therapeutic molecules, safely prevents blood clots. Approximately 100,000 Americans die annually from blood clots, or thrombosis, according to the Centers for Disease Control and Prevention.

“We have found a new thrombosis target that does not increase bleeding risk,” said senior author Daniel I. Simon, MD, President, UH Cleveland Medical Center, Herman K. Hellerstein Chair of Cardiovascular Research, and Professor of Medicine at Case Western Reserve School of Medicine. “Our discovery indicates that you can identify a new pathway and target that mediates blood clotting, but does not affect our body’s natural processes to stop bleeding, called hemostasis.”


  • News Media Access



  • Register
  • Forgot My Password
  • Search:




    Advanced Search

  • Subscribe To Our Latest News

    Subscribe to University Hospitals' RSS Feeds or Email Alerts to get our latest news.

    University Hospitals RSS Feed  University Hospitals Email Alerts
  • Twitter

    Must select a Twitter Account for Rail Gadget in Twitter Tool.

You must be logged in to view this item.



Login

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.